Skip to main content

Articles

Page 323 of 375

  1. Administration of drotrecogin alfa (activated) has been demonstrated to reduce mortality in patients with severe sepsis who are at high risk for death or who have multiple organ dysfunction. This benefit was a...

    Authors: Pierre-François Laterre and Xavier Wittebole
    Citation: Critical Care 2003 7:445
  2. Authors: ACM Duarte, KM Avena, AB Sampaio, EB Melo, EM Sena, JM Teles, MR Leite, DC Espírito-Santo, O Messeder, CM Silva and CMN David
    Citation: Critical Care 2003 7(Suppl 3):P46

    This article is part of a Supplement: Volume 7 Supplement 3